Correlation Between Aquestive Therapeutics and Mallinckrodt Plc

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Aquestive Therapeutics and Mallinckrodt Plc at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aquestive Therapeutics and Mallinckrodt Plc into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aquestive Therapeutics and Mallinckrodt Plc, you can compare the effects of market volatilities on Aquestive Therapeutics and Mallinckrodt Plc and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aquestive Therapeutics with a short position of Mallinckrodt Plc. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aquestive Therapeutics and Mallinckrodt Plc.

Diversification Opportunities for Aquestive Therapeutics and Mallinckrodt Plc

0.1
  Correlation Coefficient

Average diversification

The 3 months correlation between Aquestive and Mallinckrodt is 0.1. Overlapping area represents the amount of risk that can be diversified away by holding Aquestive Therapeutics and Mallinckrodt Plc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mallinckrodt Plc and Aquestive Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aquestive Therapeutics are associated (or correlated) with Mallinckrodt Plc. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mallinckrodt Plc has no effect on the direction of Aquestive Therapeutics i.e., Aquestive Therapeutics and Mallinckrodt Plc go up and down completely randomly.

Pair Corralation between Aquestive Therapeutics and Mallinckrodt Plc

Given the investment horizon of 90 days Aquestive Therapeutics is expected to generate 1.35 times less return on investment than Mallinckrodt Plc. But when comparing it to its historical volatility, Aquestive Therapeutics is 7.73 times less risky than Mallinckrodt Plc. It trades about 0.08 of its potential returns per unit of risk. Mallinckrodt Plc is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest  836.00  in Mallinckrodt Plc on September 14, 2024 and sell it today you would lose (790.00) from holding Mallinckrodt Plc or give up 94.5% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy29.09%
ValuesDaily Returns

Aquestive Therapeutics  vs.  Mallinckrodt Plc

 Performance 
       Timeline  
Aquestive Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Aquestive Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of conflicting performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
Mallinckrodt Plc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Mallinckrodt Plc has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent basic indicators, Mallinckrodt Plc is not utilizing all of its potentials. The latest stock price mess, may contribute to short-term losses for the institutional investors.

Aquestive Therapeutics and Mallinckrodt Plc Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Aquestive Therapeutics and Mallinckrodt Plc

The main advantage of trading using opposite Aquestive Therapeutics and Mallinckrodt Plc positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aquestive Therapeutics position performs unexpectedly, Mallinckrodt Plc can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mallinckrodt Plc will offset losses from the drop in Mallinckrodt Plc's long position.
The idea behind Aquestive Therapeutics and Mallinckrodt Plc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.

Other Complementary Tools

Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Transaction History
View history of all your transactions and understand their impact on performance